Change in Ratings
Barrington Research said it is initiating
with an outperform rating. Believes company is in an early-cycle business that should benefit from cost-reduction activity. Set $9 target price.
was upgraded to buy at Argus Research with a $37 price target. Argus notes that operating margins should benefit from lower commodity prices and China growth will continue to drive earnings.
Stock Comments/EPS Changes
Barclays Capital now sees shares of
reaching $25. It also lowered estimates to reflect an uncertain IT spending environment. Overweight rating.
This article was written by a staff member of TheStreet.com.